Product Code: ETC057445 | Publication Date: May 2021 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
The Asia Pacific (APAC) gastrointestinal drugs market is growing over the years as on account of the increasing prevalence of gastrointestinal disorders, growing geriatric population, and rising awareness about the availability of advanced treatment options. Additionally, some of the key drivers for the growth of the Asia-Pacific gastrointestinal drugs market include the rising incidence of gastrointestinal disorders. The gastrointestinal disorders such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), and Gastroesophageal Reflux Disease (GERD) are becoming increasingly common, leading to a growing demand for effective treatment options. Further, the aging population is more susceptible to gastrointestinal disorders, and this demographic is growing rapidly in many Asia-Pacific countries. In addition, the technological advancements have led to the development of new and improved drugs for the treatment of gastrointestinal disorders, which are expected to drive the growth of the market. Moreover, as awareness about the availability of advanced treatment options for gastrointestinal disorders increases, more people are seeking treatment, leading to growth in the market. Additionally, the companies operating in the Asia-Pacific gastrointestinal drugs market are investing heavily in research and development to develop new and improved drugs, which is expected to drive market growth. Further, the Asia-Pacific gastrointestinal drugs market is poised for significant growth in the coming years, driven by a combination of factors such as increasing prevalence of gastrointestinal disorders, growing geriatric population, and advancements in technology.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Asia Pacific Gastrointestinal Drugs Market Overview |
3.1 Asia Pacific Regional Macro Economic Indicators |
3.2 Asia Pacific Gastrointestinal Drugs Market Revenues & Volume, 2020 & 2027F |
3.3 Asia Pacific Gastrointestinal Drugs Market - Industry Life Cycle |
3.4 Asia Pacific Gastrointestinal Drugs Market - Porter's Five Forces |
3.5 Asia Pacific Gastrointestinal Drugs Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Asia Pacific Gastrointestinal Drugs Market Revenues & Volume Share, By Drug Category, 2020 & 2027F |
3.7 Asia Pacific Gastrointestinal Drugs Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
3.8 Asia Pacific Gastrointestinal Drugs Market Revenues & Volume Share, By Distribution Channel, 2020 & 2027F |
3.9 Asia Pacific Gastrointestinal Drugs Market Revenues & Volume Share, By Disease Types, 2020 & 2027F |
4 Asia Pacific Gastrointestinal Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Asia Pacific Gastrointestinal Drugs Market Trends |
6 Asia Pacific Gastrointestinal Drugs Market, 2017 - 2027 |
6.1 Asia Pacific Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
6.2 Asia Pacific Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
6.3 Asia Pacific Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
6.4 Asia Pacific Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
7 China Gastrointestinal Drugs Market, 2017 - 2027 |
7.1 China Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
7.2 China Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
7.3 China Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
7.4 China Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
8 India Gastrointestinal Drugs Market, 2017 - 2027 |
8.1 India Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
8.2 India Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
8.3 India Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
8.4 India Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
9 Japan Gastrointestinal Drugs Market, 2017 - 2027 |
9.1 Japan Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
9.2 Japan Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
9.3 Japan Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
9.4 Japan Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
10 Australia Gastrointestinal Drugs Market, 2017 - 2027 |
10.1 Australia Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
10.2 Australia Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
10.3 Australia Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
10.4 Australia Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
11 Indonesia Gastrointestinal Drugs Market, 2017 - 2027 |
11.1 Indonesia Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
11.2 Indonesia Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
11.3 Indonesia Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
11.4 Indonesia Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
12 Philippines Gastrointestinal Drugs Market, 2017 - 2027 |
12.1 Philippines Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
12.2 Philippines Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
12.3 Philippines Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
12.4 Philippines Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
13 Thailand Gastrointestinal Drugs Market, 2017 - 2027 |
13.1 Thailand Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
13.2 Thailand Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
13.3 Thailand Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
13.4 Thailand Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
14 Malaysia Gastrointestinal Drugs Market, 2017 - 2027 |
14.1 Malaysia Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
14.2 Malaysia Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
14.3 Malaysia Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
14.4 Malaysia Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
15 Singapore Gastrointestinal Drugs Market, 2017 - 2027 |
16 Rest of Asia Gastrointestinal Drugs Market, 2017 - 2027 |
16.1 Rest of Asia Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2017 - 2027 |
16.2 Rest of Asia Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
16.3 Rest of Asia Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
16.4 Rest of Asia Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2017 - 2027 |
17 Asia Pacific Gastrointestinal Drugs Market Key Performance Indicators |
18 Asia Pacific Gastrointestinal Drugs Market - Opportunity Assessment |
18.1 Asia Pacific Gastrointestinal Drugs Market Opportunity Assessment, By Countries, 2020 & 2027F |
18.2 Asia Pacific Gastrointestinal Drugs Market Opportunity Assessment, By Drug Category, 2020 & 2027F |
18.3 Asia Pacific Gastrointestinal Drugs Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
18.4 Asia Pacific Gastrointestinal Drugs Market Opportunity Assessment, By Distribution Channel, 2020 & 2027F |
18.5 Asia Pacific Gastrointestinal Drugs Market Opportunity Assessment, By Disease Types, 2020 & 2027F |
19 Asia Pacific Gastrointestinal Drugs Market - Competitive Landscape |
19.1 Asia Pacific Gastrointestinal Drugs Market Revenue Share, By Companies, 2020 |
19.2 Asia Pacific Gastrointestinal Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
20 Company Profiles |
21 Recommendations |
22 Disclaimer |